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TH secretion of tumour necrosis factor-ix (TNFtx),
interleukin-ltx (IL-lx) and interleukin-6 (IL-6) by a hu-
man astrocytoma cell fine was studied I h, 3 h, 6 h and
24 h after infection with tachyzoites from three
Toxoplasmagondtt strains (virulent, RH; cystogentc, 76K
and Prugniaud strains). The astrocytoma cell fine consti-
tutively secreted TNFtx and IL-6, but no IL-Ix. A positive
control was obtained by stimulation with phorbol esters
inducing a significant increase (p < 0.05) in TNFtz and IL-
6 secretion but not in IL-ltz, while lipopolysaccharide
(alone and after priming), interferon gamma, ionophore
A 23187 and sera positive to T. gondii did not induce any
increase in cytokine levels. None ofthe tachyzoites, what-
ever their virulence, induced a significant increase in
cytokine production at any time in the study. Tachyzoites
did not inhibit the secretion induced by phorbol esters.
Key words: Astrocytoma cells, Cytokine, Toxoplasma gondii
Infection with Toxoplasma gondii
does not alter TNFcx and IL-6
secretion by a human astrocytoma
cell line
H. Pelloux,1,cA J. Ricard, M.-F. Nissoufl
J.-C. Renversez,3 J.-P. Vuillez,4 A. Meunier
and P. Ambroise-Thomas
Ddpartement de Parasitologie-Mycologie
Mdicale et Moldculaire, CNRS ERS
15,Laboratoire de Neuro-Biophysique INSERM
U 318, Laboratoire de Biochimie A and
Ddpartement de Biophysique CNRS URA 1287,
Facultd de Mddecine, Universit
Joseph Fourier, Grenoble 1, 38043 Grenoble
Cedex, France
CA Corresponding Author
Introduction
Toxoplasma gondii is a worldwide intracellular
obligate parasite, which causes severe and frequent
lesions (mainly cerebral) in AIDS patients. The
pathophysiology of reactivation of toxoplasmosis in
immunocompromised patients is still not clear, and
the exact mechanisms of cyst rupture, including the
role of cytokines remain unknown. ’,3 While inter-
feron-, (INFT) is involved in protective immunity, its
precise role and mode of action is not known.
Tumour necrosis factor<z (TNF00, a cytokine which
is involved in infectious and inflammatory diseases,
has not been extensively studied in toxoplasmosis.
Its role during toxoplasmic infection in mice is con-
troversial, 5,e and TNF0t would seem to be implicated
in human and animal toxoplasmosis.7-9 Interleukin-6
(IL-6) and interleukin-lz (IL-Iz) play a role in para-
sitic diseases1 and in mouse toxoplasmosis.
11 Their
transcripts have been detected in brains of mice
infected with T. gondii." Thus, these three cytokines
(TNFx, IL-6, IL-lcz) may be involved in the develop-
ment of immunity that occurs in immunocompetent
hosts after infection with T. gondii, as they are in the
viral infections (particularly HIV).3
Cerebral parasitic multiplication following cyst re-
activation is the main event of toxoplasmic disease in
patients with Acquired Immuno Deficiency Syn-
drome, but to our knowledge, few publications have
studied the parasitic multiplication, the cyst forma-
tion and rupture in astrocytes, which are cerebral
host cells for T. gondii. Moreover, some authors
have recently suggested that differences between T.
gondii strains could be the cause of virulence differ-
ences in animals and perhaps in man, in association
with the host immunological variations. 14-17 Thus, the
aim of our work was to study the secretion of TNFz,
IL-Iz and IL-6 by a human astrocytoma cell line
infected by three T. gondii strains with different
degrees of virulence.
Materials and Methods
Astrocytoma cell fine: The GHE (Glioblastome
Humain E) cell line used for this study was derived
from a surgical specimen of a primary brain tumour
(grade II astrocytoma according to the classification
of Kernohan and WHO). Briefly, the tumour speci-
men was minced and dissociated into single cells
following incubation for 10 min in 0.5% trypsin in
DMEM medium (Sigma, St Louis, MO). TM The cell line
was then routinely grown in 25 crn" tissue culture
flasks in DMEM medium supplemented with 10%
foetal calf serum (DAP, Vogelgrun, France) and an-
tibiotics (100 U penicillin and 50 t.tg streptomycin per
ml). Culture was maintained at 37C in humidified air
containing 5% CO2, and cells were subcultured when
confluent.
After establishment, growth curves and cell dou-
bling times were determined. The morphological
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features of the cell line were recorded with a phase-
contrast microscope and camera. The glial origin of
the cells was established by the presence of the glial
fibrillary acidic protein (GFAP) and the S100 protein,
markers for astrocytic differentiation, and with mor-
phological histological criteria as described else-
where. 18
The absence of Mycoplasma contamination was
checked using the Mycoplasma detection kit from
Boehringer (Meylan, France).
Toxoplasma gondii strains: Three T. gondii strains
were used: the virulent RH, and the chronic 76K and
Prugniaud strains. 15a9 The RH strain never forms cysts
in mice, and infection kills mice after 3 or 4 days. In
contrast, mice infected with the 76K and the
Prugniaud strains do not die and cysts are present in
mouse brains. The RH strain was obtained by in vitro
culture in human fibroblast MRC5 cells (bioM(rieux,
Marcy l’Etoile, France). The RH tachyzoites were
collected from the culture supernatant (1200 xg for
10 min) after 4 days and then counted in a Neubauer
cell. The Prugniaud and 76K tachyzoites were ob-
tained after inoculation of Swiss mice (OF1 strain, Iffa
Credo, L’Arbresle, France) treated with
corticosteroids. Briefly, mice received 1 mg i.m. of
hydrocortisone acetate (Roussel, Paris, France) for
5 days. Tachyzoites were injected intraperitoneally,
and cortisone treatment was prolonged for 10 days.
After tachyzoite multiplication, the peritoneal fluid
was harvested, the tachyzoites were washed
(1200 xg for 10 min) and counted. Their viability
was assayed by the ethidium bromide-acridine or-
ange assay (Becton Dickinson, Oxnard, CA), and
only parasite preparations with a viability > 95% were
used.
7Fot assay: The immunoradiometric assay kit for
detection of human TNFtz (Medgenix, Brussels, Bel-
gium) was used. The medium containing astrocytes
or parasites was free of TNFtx (< 6 pg/ml).
IL-Iz and IL-6 assay: The techniques used were the
competitive sandwich immuno enzymatic methods
(Immunotech, Marseille, France) for IL-6 and IL-ltx
interleukins. The medium containing astrocytes and
parasites was free of these cytokines (< 20 pg/ml).
Study of cytokine secretions: The GHE cells were
distributed into 24-well plates at 1.5 x 104 cells per
well in 1 ml of culture medium and then left to
multiply for 1 week at 37C, 5% CO,.. Experiments
were performed when the cell monolayers were
confluent (approximately 1.5 x 105 cells per welD.
Fresh medium was added to the cells at TO.
T. gondii tachyzoites of the different strains
(1.5 x 105 per well) were added to the wells at TO.
The ratio cells:parasites was then of approximately
1:1. In some experiments, 106 parasites were added
to the wells.
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Depending on the experiments, lipopoly-
saccharide (LPS) (10 or 1 l.tg/ml; Calbiochem,
Meudon, France), positive sera, human recombinant
interferon-g (INF,,) (100 U/ml); Boehringer, Meylan,
France), phorbol esters (phorbol-12-myristate-13-ac-
etate (PMA) 10-8 M; Sigma, St Louis, MO), ionophore
A 23187 (10-6 M; Sigma), or polymyxin B (1 }.tg/ml;
Pfizer, Orsay, France) in order to inhibit LPS action,
were added to the wells at TO.
Supernatants were collected from corresponding
wells at different times (1 h, T1; 3 h, T2; 6 h, T3;
24 h, T4). For some experiments, parasites were al-
lowed to grow in cells for 2 h before stimulation.
Immunofluorescence staining: The presence of para-
sites in GHE cells was revealed by indirect
immunofluorescence staining. The cell monolayer
was fixed and then dried. A rabbit polyclonal anti-
Toxoplasma antibody was added and incubated for
30 min at 37C. After washing, a fluorescein-labelled
anti-rabbit IgG antibody (Institut Pasteur, France)
was used to reveal the presence of parasites with an
UV light microscope.
Positive sera: Twelve sera were collected from twelve
patients with high levels of IgG antibodies to T.
gondii (640 to 1280 IU/ml, indirect fluorescent anti-
body technique).
Statistical analysis: A statistical analysis was per-
formed using analysis of variance and Kolmogorov-
Smirnov tests.
Results
Infection of GHE cells: The percentage of cells in-
fected by T. gondii (assessed by immuno-
fluorescence staining) was 10% after 1 h and 25%
after 24 h when 105 parasites of the RH strain were
added to the cells. When 106 parasites were added,
those percentages were 20% and 45% respectively.
Those infection rates were not significantly different
with the parasites from the chronic strain, but the
average numbers of parasites per infected cell were
higher for the virulent strain--approximately 5 para-
sites/cell for the RH strain after 24 h, and less than
2 parasites/cell for 76K. These infection rates were
not significantly modified by INF), (100 U/ml).
The microscopic examination showed areas of
lysed cells in the case of infection by the RH strain,
which were not present in the case of infection with
chronic strains.
Secretions without stimulation (negative control): In
our experimental conditions, the astrocytoma cell
line constitutively secreted low amounts of TNF0t
(Fig. 1), higher amounts of IL-6 (Fig. 2) and no IL-I.
The secretions of TNFcz and IL-6 increased with time
of sampling (the medium was changed at TO). No
decrease in secretion was observed when polymyxinT. gondii, astrocytoma cells and cytokines
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FIG. 1. TNF produced by astrocytoma cells. The values forTNF( represent
the mean of nine experiments with astrocytoma cells alone (control), five
experiments with cells plus LPS (10 p.g/ml) or INF7 (100 U/ml), four experi-
ments with cells plus PMA (10 M), four experiments with cells plus RH T.
gondii strain, two experiments with cells plus 76K strain and three experi-
ments with cells plus Prugniaud strain. The supematants were collected
h, 3 h, 6 h and 24 h after stimulation. The same results were obtained with
LPS at Ig/ml. The results with astrocytoma cells alone were not modified
by addition of polymyxin B (1 lg/ml). Error bars represent one standard
deviation.
B was added. After 48 h, the cytokine levels were not
different from those noted after 24 h (data not
shown).
Positive controls: Cells from the GHE cell line were
able to secrete significantly (p < 0.05) higher amounts
of TNF(z and IL-6 at T2, T3 and T4 when stimulated
by PMA than after each of the other stimulations (Figs
1 and 2). In this case the viability of the cells re-
mained high (> 95%). DMSO (dimethylsulfoxide;
Sigma) alone, the diluent of the PMA, did not induce
any secretion.
Moreover, LPS alone (10 and 1 l.tg/ml), INF alone
(100 U/ml), ionophore alone (10-6 M), INF plus LPS
at the same time, or cell priming by INF7 (8 h) and
then addition of LPS, did not induce a significant
increase in secretion of cytokine by these cells.
Different parasite numbers (10 or 10 tachyzoites)
did not modify the cytokine secretions. In our experi-
ments, the cytokine (TNF(x and IL-6) levels were
significantly lower (p < 0.05) at T1 than at T2, T3 or
T4 after PMA stimulation.
No secretion depending on the strains: The multipli-
cation of T. gondii tachyzoites did not induce the
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FIG. 2. IL-6 produced by astrocytoma cells. Details are the same as given
in the legend to Fig. except that IL-6 was used instead of TNF.
secretion of the three cytokines by the astrocytoma
cells (Figs 1 and 2) whatever the strain used. The
twelve IgG positive sera to T. gondii gave the same
results.
The penetration of parasites into the cells during
2 h before the experiment did not inhibit the secre-
tions induced by PMA (Figs 3 and 4).
Discussion
The results show that the GHE cell line constitu-
tively secretes TNF0t and large amounts of IL-6, but
no detectable IL-I(z before 24 h. The constitutive
secretion of TNF0 is not constant in human
astrocytoma cell lines: Bethea et al. report that
TNF(x secretion was obtained only after stimulation
in the CH235-MG cell line. The astrocytoma cells we
studied do not respond to LPS and INF7 stimulation,
even after priming by INFT, contrary to the data
reported by Chung and Benveniste.2 These results
are not surprising since cytokine expression or secre-
tion by glial cells are very different depending on the
cell origins and the stimulation. ’2-’s We did not ob-
serve any secretion of IL-I induced by previous
TNF secretion, as reported in a mouse model after
LPS stimulation.’6 Chang et al.n showed that, in mice,
the anti-T, gondii action of INF7 depends partly on
the TNF production induced by INF7 itself.
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FIG. 3. TNF produced by astrocytoma cells after infection and PMA. Data
obtained from one representative experiment obtained with the RH strain.
Astrocytoma cells were infected with T. gondii and 2 h later PMA was
added, simultaneously in the wells without parasites. Supernatants were
collected h, 3 h, 6 h and 24 h after PMA addition.
The virulent RH strain did not induce secretion of
any of the three cytokines, when compared with the
secretions observed with astrocytoma cells alone.
Such data are consistent with our previous studies on
human monocytes and macrophages concerning
TNFo8 and with the study of Friedland27 on secretion
of TNFot and IL-6 by a human monocytic cell line, but
is different from the results obtained after infection
of murine mononuclear cells by Leishmania
infantum which is another obligate intracellular pro-
tozoan. 28 However, the intracellular behaviour of T.
gondii and L. infantum is not the same, especially
concerning the mechanisms used to escape
intracellular killing, which could lead to differences
in the induction of TNF secretion.
The present model may mimic what happens after
cyst rupture: tachyzoites from cystogenic strains en-
ter brain cells around the cyst where they multiply.
Sera with high anti-Toxoplasma IgG antibody titres
did not induce this type of secretion, in contrast to
what was shown with blood monocytes and
monocyte-derived macrophages. The presence of
exogenous INFT, simultaneously with TNF and
IL-6 secreted by GHE cells did not lead to a decrease
in infection rates. Our results are similar to those
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FIG. 4. IL-6 produced by astrocytoma cells after infection and PMA. Other
details are the same as given in the legend to Fig. 3.
from Chao et al.z9 and Peterson et al.3 comparing
microglial cells and astrocytes in a murine model.
Thus, the protective role of cerebral endogenous,
astrocyte-secreted, TNFot is still unclear in man, even
though it has been demonstrated to be an important
factor of resistance to T. gondii infection in mice.6,31
The causes of the different degrees of virulence
between T. gondii strains are not understood. The
genotypic and phenotypic variations between the T.
gondii strains have been demonstrated for enzymatic
activities, RFLP and pathogenicity in animals and
humans. 15-17 From our results, the different strains do
not induce different cytokine profiles in response to
a parasitic infection. Thus the assumed differences
between strains, which could explain the onset of
cerebral reactivation in AIDS patients, do not seem
to be mediated by astrocyte cytokine production.
However, cytokines produced by other cerebral
cells, such as microglial cells, or recruited inflam-
matory cells (lymphocytes, macrophages and/or
polymorphonuclear) might have an .influence on
parasitic multiplication and cyst rupture. Moreover,
human monocytes and macrophages may secrete
TNF in the presence of specific anti-Toxoplasma
antibodies.8
In conclusion the T. gondii protozoan does not
induce (or prevent) cytokine secretion by human
astrocytoma derived cells.T. gondii, astrocytoma cells and cytokines
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